abrdn Life Sciences Investors Stock Price, News & Analysis
Company Description
abrdn Life Sciences Investors (NYSE: HQL) is a publicly traded asset management company in the Financial Services sector. The company has a market capitalization of $481.9M, ranking #3,484 among all listed U.S. companies by market cap.
HQL stock has gained 24.4% over the past year, placing it at #1,031 in year-to-date performance among tracked companies. Shares last traded at $16.23.
This page provides a comprehensive overview of HQL stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
abrdn Life Sciences Investors (HQL) stock last traded at $16.23, down 0.37% from the previous close. Over the past 12 months, the stock has gained 24.4%, ranking #559 in 52-week price change. At a market capitalization of $481.9M, HQL is classified as a small-cap stock with approximately 28.9M shares outstanding.
Latest News
abrdn Life Sciences Investors has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 3 with negative movement. Key topics include buybacks. View all HQL news →
SEC Filings
abrdn Life Sciences Investors has filed 5 recent SEC filings, including 3 Form SCHEDULE 13D/A, 1 Form 3, 1 Form SCHEDULE 13G/A. The most recent filing was submitted on March 6, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all HQL SEC filings →
Financial Highlights
Upcoming Events
Short Interest History
Short interest in abrdn Life Sciences Investors (HQL) currently stands at 37.9 thousand shares, down 37.6% from the previous reporting period, representing 0.1% of the float. Over the past 12 months, short interest has decreased by 50.3%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for abrdn Life Sciences Investors (HQL) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
HQL Company Profile & Sector Positioning
abrdn Life Sciences Investors (HQL) operates in the Asset Management industry within the broader Financial Services sector and is listed on the NYSE. Among dividend-paying stocks, HQL ranks #49 by dividend yield. In monthly performance, the stock ranks #360 among all tracked companies.
Investors comparing HQL often look at related companies in the same sector, including BlackRock Health Sciences (BME), BlackRock MuniVest (MVF), abrdn World Healthcare (THW), Palmer Square Capital Bdc Inc. (PSBD), and First Trust Enhanced Equity Income (FFA). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate HQL's relative position within its industry.